Evidence map›Paper›PMID 31683640›Full record

ArticleInternational journal of molecular sciences2019

Dp71 Expression in Human Glioblastoma.

Simona Ruggieri, Michelina De Giorgis, Tiziana Annese, Roberto Tamma, Angelo Notarangelo, Andrea Marzullo, Rebecca Senetta, Paola Cassoni, Michela Notarangelo, Domenico Ribatti and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. The Duchenne muscular dystrophy gene and cancer.Cellular oncology (Dordrecht, Netherlands) · 2021
    Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Simona RuggieriDepartment of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Medical School, 70124 Bari, Italy. simona.ruggieri@uniba.it.
Michelina De GiorgisDepartment of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Medical School, 70124 Bari, Italy. michelina.degiorgis@uniba.it.
Tiziana AnneseDepartment of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Medical School, 70124 Bari, Italy. tiziana.annese@uniba.it.ORCID 0000-0002-7752-0368
Roberto TammaDepartment of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Medical School, 70124 Bari, Italy. roberto.tamma@uniba.it.
Angelo NotarangeloMedical Genetic Unit, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, 71013 Foggia, Italy. a.notarangelo@operapadrepio.it.
Andrea MarzulloDepartment of Emergency and Transplantation, Pathology Unit, University of Bari Medical School, 70124 Bari, Italy. andrea.marzullo@uniba.it.
Rebecca SenettaPathology Unit, Department of Medical Sciences, University of Turin, University of Turin Medical School, 10124 Turin, Italy. rebecca.senetta@unito.it.
Paola CassoniPathology Unit, Department of Medical Sciences, University of Turin, University of Turin Medical School, 10124 Turin, Italy. paola.cassoni@unito.it.
Michela NotarangeloCentre for Integrative Biology, CIBIO, University of Trento, 38123 Trento, Italy. michela.notarangelo@unitn.it.
Domenico RibattiDepartment of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Medical School, 70124 Bari, Italy. domenico.ribatti@uniba.it.ORCID 0000-0003-4768-8431
Beatrice NicoDepartment of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Medical School, 70124 Bari, Italy. beatrice.nico@uniba.it.
University of Bari Aldo Moro · ITUniversity of Turin · ITCasa Sollievo della Sofferenza · ITUniversity of Trento · IT

Funding

Associazione Italiana per la Ricerca sul Cancro 20879
6 · The paper itself

Abstract

backgroundDp71 is the most abundant dystrophin (

methodsDp71 expression was analyzed by immunofluorescence, immunohistochemistry, RT-PCR, and immunoblotting in glioblastoma cell lines and cells isolated from human glioblastoma multiforme (GBM) bioptic specimens.

resultsDp71 isoform was expressed in normal human astrocytes (NHA) cell lines and decreased in glioblastoma cell lines and cells isolated from human glioblastoma multiforme bioptic specimens. Moreover, Dp71 was localized in the nucleus in normal cells, while it was localized into the cytoplasm of glioblastoma cells organized in clusters. We have shown, by double labeling, that Dp71 colocalizes with lamin B in normal astrocytes cells, confirming the roles of Dp71 and lamin B in maintaining nuclear architecture. Finally, we demonstrated that decreased Dp71 protein in cells isolated from human bioptic specimens was inversely correlated with the Ki-67 tumor proliferative index.

conclusionA decreased Dp71 expression is associated with cancer proliferation and poor prognosis in glioblastoma.

Indexed as

AdultAgedAged, 80 and overAstrocytesBrain NeoplasmsCell Line, TumorCell ProliferationCells, CulturedDystrophinFemaleGene Expression Regulation, NeoplasticGlioblastomaHumansLamin Type BMaleMiddle Agedapo-dystrophin 1DystrophinLamin Type BDp71glioblastomalamin Btumor progression

Identifiers

PMID31683640
PMCPMC6862465
OpenAlexW2982577914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.